ANAB – AnaptysBio Inc

AnaptysBio, Inc.

ANAB

$51.63

Name : AnaptysBio, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $1,502,479,616.00

EPSttm : -1.02

AnaptysBio, Inc.

$51.63

0.53%

$0.27

ANAB — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

17.61

Margin Of Safety %

-2

Put/Call OI Ratio

2.02

EPS Next Q Diff

2.31

EPS Last/This Y

0.83

EPS This/Next Y

5.46

Price

51.63

Target Price

73.18

Analyst Recom

1.09

Performance Q

24.91

Upside

-127.2%

Beta

0.89

Ticker: ANAB

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-11	ANAB	67.97	4.20	5.75	5533
2026-05-12	ANAB	65.54	4.24	6.58	5551
2026-05-13	ANAB	62.69	4.29	3.11	5633
2026-05-14	ANAB	62.09	4.24	4.57	5718
2026-05-15	ANAB	63.22	4.29	0.70	5735
2026-05-18	ANAB	58.68	8.27	0.01	2530
2026-05-19	ANAB	59.87	1.99	0.00	3403
2026-05-20	ANAB	59.98	1.98	0.00	3414
2026-05-21	ANAB	60.41	1.96	999.99	3429
2026-05-22	ANAB	59.65	1.96	0.00	3430
2026-05-26	ANAB	57.72	1.96	0.32	3427
2026-05-27	ANAB	57.66	1.98	999.99	3426
2026-05-28	ANAB	56.95	1.99	0.33	3440
2026-05-29	ANAB	55.68	1.99	0.10	3443
2026-06-02	ANAB	51.25	2.01	0.50	3471
2026-06-03	ANAB	51.2	2.01	0.00	3470
2026-06-04	ANAB	51.64	2.02	1.00	3467
2026-06-05	ANAB	50.43	2.02	1.00	3467
2026-06-08	ANAB	51.39	2.01	999.99	3467
2026-06-09	ANAB	51.62	2.02	0.00	3471
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-11	ANAB	67.93	41.2	-113.9	0.89
2026-05-12	ANAB	65.38	41.2	-112.9	0.89
2026-05-13	ANAB	62.71	41.2	-112.5	0.89
2026-05-14	ANAB	62.16	41.2	-103.8	0.89
2026-05-15	ANAB	63.14	41.2	-105.1	0.89
2026-05-18	ANAB	58.74	41.2	-100.3	0.60
2026-05-19	ANAB	59.84	41.2	-105.3	0.60
2026-05-20	ANAB	60.07	131.9	-104.6	0.60
2026-05-21	ANAB	60.40	131.9	-104.7	0.60
2026-05-22	ANAB	59.69	131.9	-103.6	0.60
2026-05-26	ANAB	57.68	129.1	-102.4	0.37
2026-05-27	ANAB	57.68	129.1	-104.2	0.37
2026-05-28	ANAB	56.96	129.1	-103.6	0.37
2026-05-29	ANAB	55.65	129.1	-102.9	0.37
2026-06-01	ANAB	53.10	129.1	-101.6	0.37
2026-06-02	ANAB	51.44	129.1	-102.5	0.37
2026-06-03	ANAB	51.23	129.1	-104.3	0.37
2026-06-04	ANAB	51.68	129.1	-104.8	0.37
2026-06-05	ANAB	50.43	129.1	-102.9	0.37
2026-06-08	ANAB	51.38	129.1	-105.4	0.37
2026-06-09	ANAB	51.63	129.1	-104.6	0.37
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-11	ANAB	-9.25	-5.71	15.10
2026-05-12	ANAB	-9.25	-5.71	16.41
2026-05-13	ANAB	-9.25	-5.71	16.41
2026-05-14	ANAB	-9.25	-5.71	16.41
2026-05-15	ANAB	-9.25	-5.71	16.41
2026-05-18	ANAB	-9.25	-5.81	16.41
2026-05-19	ANAB	-9.25	-5.81	16.41
2026-05-20	ANAB	-9.25	-5.81	16.41
2026-05-21	ANAB	-9.25	-5.81	16.38
2026-05-22	ANAB	-9.42	-5.81	16.38
2026-05-26	ANAB	-9.42	2.89	16.38
2026-05-27	ANAB	-9.42	2.89	16.38
2026-05-28	ANAB	-9.42	2.89	17.61
2026-05-29	ANAB	-9.42	2.89	17.61
2026-06-02	ANAB	-9.42	2.36	17.61
2026-06-03	ANAB	-9.42	2.36	17.61
2026-06-04	ANAB	-9.42	2.36	17.61
2026-06-05	ANAB	-9.42	2.36	17.61
2026-06-08	ANAB	-9.42	2.36	17.61
2026-06-09	ANAB	-9.42	2.36	17.61
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-1.84

Avg. EPS Est. Current Quarter

0.39

Avg. EPS Est. Next Quarter

0.47

Insider Transactions

-9.42

Institutional Transactions

2.36

Beta

0.89

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

50.68

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

28.6

Max Drawdown 5-Year %

-69.3

Target Price

73.18

P/E

Forward P/E

PEG

P/S

6.47

P/B

117.58

P/Free Cash Flow

340.7

EPS

-1.08

Average EPS Est. Cur. Y

0.37

EPS Next Y. (Est.)

5.83

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-11.53

Relative Volume

0.52

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

-0.2

EPS 1 30Days Diff

0.53

EBIT Estimation

-104.6

◆ ANAB Healthcare

$51.63

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

6/20

Pullback

25/25

Volume

11/15

Valuation

12/20

TP/AR

2/10

Options

3/10

RSI

37.8

Range 1M

7.8%

Sup Dist

3.1%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

3/25

Growth

4/30

Estimates

5/20

Inst/Vol

8/15

Options

4/10

EPS Yr

-563.8%

EPS NY

-15.1%

52W%

66%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +31.2% upside

Quality

9/30

Valuation

9/30

Growth

0/25

Stability

6/10

LT Trend

3/5

Upside

+31.2%

Quality

MoS

-2%

AnaptysBio, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 104

AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics for autoimmune and inflammatory diseases in the United States. The company's products include Rosnilimab, a selective pathogenic T cell deplete which completed a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis; ANB033, a CD122 antagonist, which is in a Phase 1b trial for celiac disease and eosinophilic esophagitis; ANB101, a BDCA2 modulator antibody which is in Phase 1a trial that specifically targets plasmacytoid dendritic cells and inhibits interferon secretion and modulates antigen presentation; dostarlimab, a PD-1 antagonist for various solid tumor indications; and Imsidolimab, an antibody that inhibits the interleukin-36 receptor, which is in the Phase 3 development for the treatment of generalized pustular psoriasis. It focuses on developing various antibody programs that are advanced to preclinical and clinical milestones under its collaborations. It has collaborations agreement with GSK and Vanda. The company was formerly known as Anaptys Biosciences, Inc. and changed its name to AnaptysBio, Inc. in July 2006. AnaptysBio, Inc. was incorporated in 2005 and is based in San Diego, California.

ANAB

Latest News

—

Caricamento notizie per ANAB…

stock quote shares ANAB – AnaptysBio Inc Stock Price stock today

news today ANAB – AnaptysBio Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch ANAB – AnaptysBio Inc yahoo finance google finance

stock history ANAB – AnaptysBio Inc invest stock market

stock prices ANAB premarket after hours

ticker ANAB fair value insiders trading

ANAB – AnaptysBio Inc

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ANAB

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y